XML 61 R51.htm IDEA: XBRL DOCUMENT v3.22.2
Equity Incentive Plans and Stock-Based Compensation - Additional Information (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jun. 10, 2021
shares
Nov. 30, 2021
USD ($)
shares
Jun. 30, 2022
USD ($)
$ / shares
shares
Jun. 30, 2021
USD ($)
Dec. 31, 2021
Jun. 15, 2022
shares
Mar. 31, 2022
shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Shares reserved for future issuance | shares     155,472,788       144,601,515
Exchange ratio of common stock     2.293698169        
Granted | shares     1,700,512        
Shares Available for Grant, Exercised | shares     1,065,784        
Weighted-average grant date fair values of options granted | $ / shares     $ 2.44        
Intrinsic value of vested options exercised | $     $ 1,500 $ 5,700      
Unrecognized stock-based compensation cost | $     $ 93,800        
Weighted average period over which unrecognized compensation is expected to be recognized     2 years 9 months 18 days        
Stock-based compensation expense | $     $ 30,462 9,637      
Proceeds from stock options exercised | $     1,533 2,720      
Lemonaid Health, Inc. [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Vesting period   4 years          
Unrecognized stock-based compensation cost | $     36,700        
Weighted average period over which unrecognized compensation is expected to be recognized   3 years 3 months 18 days          
Common stock granted subject to vest | shares   3,747,027          
Common stock granted subject to vest, Weighted average grant date fair value | $   $ 43,900          
General and Administrative Expense [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Stock-based compensation expense | $     12,170 2,329      
General and Administrative Expense [Member] | Lemonaid Health, Inc. [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Stock-based compensation expense | $     2,700        
Stock Option Activity [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Tax benefit recognized from stock option exercises | $     0 $ 0      
Restricted Stock Units [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Unrecognized stock-based compensation cost | $     $ 131,000        
Weighted average period over which unrecognized compensation is expected to be recognized     3 years 6 months        
Maximum [Member] | Restricted Stock Units [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Vesting period         4 years    
Minimum [Member] | Restricted Stock Units [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Vesting period         1 year    
2021 Incentive Equity Plan [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Exchange ratio of common stock     2.293698169        
Shares Available for Grant, Beginning balance | shares     22,839,019        
Common stock issued and outstanding, percentage     3.00%        
Exercise price of stock options as a percentage of fair value of shares     110.00%        
Share-based payment award, description     The number of shares of Class A common stock reserved for issuance under the 2021 Plan will automatically increase on January 1 of each calendar year, starting in 2022, in an amount equal to (i) 22,839,019 shares of Class A common stock, (ii) 3.0% of the aggregate number of shares of Class A common stock and Class B common stock outstanding, or (iii) a lesser number of shares determined by the Company’s Board of Directors prior to the applicable January 1 (the “Evergreen Provision”).        
Share-based payment award, expiration period     10 years        
Share-based compensation terms of award     Options under the 2021 Plan have a contractual life of up to ten years. The exercise price of a stock option shall not be less than 100% of the estimated fair value of the shares on the date of grant, as determined by the Board of Directors.        
2021 Incentive Equity Plan [Member] | Stock Option Activity [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Percentage of total stock holding     10.00%        
2021 Incentive Equity Plan [Member] | Minimum [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Exercise price of stock options as a percentage of fair value of shares     100.00%        
ESPP [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Common stock issued and outstanding, percentage (1.00%)            
Amount withheld | $     $ 2,300        
Potential annual increase in shares reserved for future issuance | shares 5,000,000            
Number of shares issued | shares     0        
2006 Equity Incentive Plan | Performance Based Awards [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Granted | shares     0        
2022 AIP [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Stock-based compensation expense | $     $ 5,000        
Class A Common Stock [Member] | 2021 Incentive Equity Plan [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Shares reserved for future issuance | shares 136,000,000         13,384,415  
Class A Common Stock [Member] | 2021 Incentive Equity Plan [Member] | Lemonaid Health, Inc. [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Shares reserved for future issuance | shares   2,990,386          
Class A Common Stock [Member] | 2021 Incentive Equity Plan [Member] | Maximum [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Shares reserved for future issuance | shares 136,000,000            
Class A Common Stock [Member] | ESPP [Member]              
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]              
Shares reserved for future issuance | shares 11,420,000